The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments

Chronic plaque psoriasis is an inflammatory skin disease affecting 2–3% of the general population. Approximately one-third of patients are candidates for systemic immunosuppressive treatments, such as synthetic or biological disease-modifying antirheumatic drugs, because of disease extensions, local...

Descripción completa

Detalles Bibliográficos
Autores principales: Gisondi, Paolo, Bellinato, Francesco, Chiricozzi, Andrea, Girolomoni, Giampiero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761600/
https://www.ncbi.nlm.nih.gov/pubmed/33276686
http://dx.doi.org/10.3390/vaccines8040728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761600/
https://www.ncbi.nlm.nih.gov/pubmed/33276686
http://dx.doi.org/10.3390/vaccines8040728

Ejemplares similares